<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/BD01AFDB-BB9D-4A34-844B-884B30BDE99E"><gtr:id>BD01AFDB-BB9D-4A34-844B-884B30BDE99E</gtr:id><gtr:name>Intensichem Limited</gtr:name><gtr:address><gtr:line1>Intensichem,Discovery Park House,Ramsgate Road</gtr:line1><gtr:city>Sandwich</gtr:city><gtr:postCode>CT13 9ND</gtr:postCode><gtr:region>South East</gtr:region></gtr:address><gtr:typeInd>P</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/BD01AFDB-BB9D-4A34-844B-884B30BDE99E" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>BD01AFDB-BB9D-4A34-844B-884B30BDE99E</gtr:id><gtr:name>Intensichem Limited</gtr:name><gtr:address><gtr:line1>Intensichem,Discovery Park House,Ramsgate Road</gtr:line1><gtr:city>Sandwich</gtr:city><gtr:postCode>CT13 9ND</gtr:postCode><gtr:region>South East</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_PARTICIPANT</gtr:name></gtr:role><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>17550.0</gtr:offerGrant><gtr:projectCost>23400.0</gtr:projectCost></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/805B95A8-728D-457C-8A00-4F5E4E908963" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="gtr:organisationParticipantRole"><gtr:id>805B95A8-728D-457C-8A00-4F5E4E908963</gtr:id><gtr:name>Asynt Limited</gtr:name><gtr:address><gtr:line1>ELDO HOUSE KEMPSON WAY , SUFFOLK BUSINESS PARK</gtr:line1><gtr:city>BURY ST. EDMUNDS</gtr:city><gtr:postCode>IP32 7AR</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PARTICIPANT</gtr:name></gtr:role></gtr:roles><gtr:offerGrant>7425.0</gtr:offerGrant><gtr:projectCost>9900.0</gtr:projectCost></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/6BAA32D3-0592-4662-8707-B8FF49287B99"><gtr:id>6BAA32D3-0592-4662-8707-B8FF49287B99</gtr:id><gtr:firstName>Unknown</gtr:firstName><gtr:otherNames>Unknown</gtr:otherNames><gtr:surname>Unknown</gtr:surname><gtr:roles><gtr:role><gtr:name>PROJECT_MANAGER</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=131085"><gtr:id>FA601434-CA70-49A9-B31B-E4D8DB8DF56C</gtr:id><gtr:title>Scalable flow ozonolysis for laboratory and commercial manufacturing</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Feasibility Studies</gtr:grantCategory><gtr:grantReference>131085</gtr:grantReference><gtr:abstractText>Ozonolysis is a potentially very valuable, sustainable chemical process. Its industrial application is limited by difficulties with scaling up due to its highly energetic nature and associated explosion hazards. IntensiChem has identified a novel process technology concept which will allow the chemical industry to exploit clean, efficient and sustainable manufacturing using commercial flow ozonolysis. The concept's design ensures that successful scalability is assured.
It is important to provide industry with the appropriate tools to make their own assessment of the potential of any commercial process or technology. We will partner with Asynt, an innovative UK SME, to bring the concept to the commercial laboratory. Ultimately the chemical manufacturing industry will have a complete solution, from laboratory to plant.</gtr:abstractText><gtr:fund><gtr:end>2013-06-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/E18E2F0F-AC7D-4E02-9559-669F7C8FEC74"><gtr:id>E18E2F0F-AC7D-4E02-9559-669F7C8FEC74</gtr:id><gtr:name>Innovate UK</gtr:name></gtr:funder><gtr:start>2013-03-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>24975</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">131085</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>